Moderna Inc (NAS:MRNA)
$ 141.01 8.11 (6.1%) Market Cap: 54.04 Bil Enterprise Value: 43.65 Bil PE Ratio: 0 PB Ratio: 4.21 GF Score: 68/100

Moderna Inc Corporate Analyst Meeting Transcript

Sep 17, 2020 / 12:00PM GMT
Release Date Price: $67.89 (-1.38%)
Operator

Good morning and welcome to Moderna's Annual R&D Day. (Operator Instructions) Please be advised that this call is being recorded. At this time, I'd like to turn the call over to Lavina Talukdar, Head of Investor Relations at Moderna. Please proceed.

Lavina Talukdar
Moderna, Inc. - Head of IR

Thank you, Catherine. Good morning, everyone. Thank you for joining Moderna's R&D Day. Today, we will present new data and updates of many of our pipeline candidates. You will hear from Moderna's management and clinical team leads as well as from key opinion leaders. You can access the press release issued this morning as well as the slides that we'll be reviewing by going to the Investors section of our website. Presenting today from Moderna are Stéphane Bancel, our Chief Executive Officer; Tal Zaks, our Chief Medical Officer; Stephen Hoge, our President; Juan Andres, Chief Technical Operations and Quality Officer; Jacqueline Miller, Senior Vice President, Infectious Diseases; Lori Panther, Senior Director, Clinical Development, Infectious Diseases; and Allison

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot